Immunohistochemical Assessment of HER3 Expression in Pancreatic Cancer
Pancreatic cancer (PC) is one of the most lethal tumor malignancies, which has a poor prognosis and can be the cause of death despite tumor removal. New molecular investigations for therapeutic purposes have shown the expression of HER3 in pancreatic adenocarcinoma. Family receptors HER3 pl...
Saved in:
Main Authors: | Hosnie Hoseini, Azade Sarani |
---|---|
Format: | Article |
Language: | English |
Published: |
Krupanidhi College of Pharmacy
2024-06-01
|
Series: | Journal of Pharmaceutical Research |
Online Access: | https://jopcr.com/articles/immunohistochemical-assessment-of-her3-expression-in-pancreatic-cancer |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of PD-1 Gene Susceptibility and Prognosis in Breast Cancer Patients in Iranian Population
by: Hosnie Hoseini, et al.
Published: (2024-11-01) -
PIK3CA mutations in breast cancer with low HER2 / neu expression
by: I. A. Pavlenko, et al.
Published: (2022-12-01) -
Relationship of Immunohistochemical Expression of CD86/CD163 Positive Intratumoral Macrophages with Prognosis of Pancreatic Ductal Adenocarcinoma
by: Goran Glavčić, et al.
Published: (2024-01-01) -
Features of expression of immunohistochemical markers in local and generalized clear cell kidney cancer
by: E. M. Frantsiyants, et al.
Published: (2020-03-01) -
CLINICAL CHARACTERISTICS OF BREAST CANCER WITH STEROID RECEPTORS EXPRESSION AND HER2 AMPLIFICATION
by: F. V. Moiseenko, et al.
Published: (2017-02-01)